Drug Trial Radar · NCT01697319
Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
Last checked: Nov 20, 2026Latest source record: Jan 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
16
Actual
Start
Aug 2012
Primary completion
Oct 2014
Study completion Oct 2014
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Oct 2, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the effect of 2.0 mg/kg/week BMN 110 in a patient population that has limited ambulation, in a period of up to 144 weeks.
Conditions
- Mucopolysaccharidosis IVA
- Morquio A Syndrome
- MPS IVA
Interventions
BMN 110Drug
Drug will be delivered through a 4 hour (approximate) IV infusion at a dosage amount of 2.0 mg/kg/week for up to 144 weeks of treatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Speed as Measured in Functional Dexterity Test (FDT)Time frame: Up to 96 weeks
- Change From Baseline in Strength as Assessed by Grip and Pinch Test (GPT)Time frame: Up to 96 weeks
- Percent Change From Baseline in Speed as Measured in Timed 25-Foot Walk Test (25FWT)Time frame: Up to 96 weeks
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
Children's Hospital & Research Center Oakland
Oakland, California
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Universitätsklinikum Hamburg
Hamburg, Germany
University Medical Center Mainz, Center of Pediatric and Adolescent Medicine Villa Metabolica
Mainz, Germany
NIHR/Wellcome Trust Birmingham CRF, Queen Elizabeth Hospital
Birmingham, United Kingdom
Central Manchester University Hospitals NHS Foundation Trust
Manchester, United Kingdom
Salford Royal NHS Foundation Trust
Salford, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.